About us

OUR COMPANY

SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA DDM Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1,000 institutions to benefit from knowledge sharing, fostering a new era in healthcare. SOPHiA GENETICS achievement is recognized by the MIT Technology Review’s “50 Smartest Companies”.

Please visit us at https://www.sophiagenetics.com for more information about the company.

What they say
about Alamut

"We are very pleased with Alamut since it conveniently streamlines post-sequencing analyses of detected variants. We value the programme user friendliness and its all-in one approach to variant analysis."

PROF. MILAN MACEK Jr. M.D. Ph.D.
Charles University, Prague

For Research Use Only. Not for Use in Diagnostic Procedures. The information included has been prepared for and is intended for viewing by a global audience. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult local sales representatives.

© 2021 SOPHiA GENETICS. All rights reserved. All trademarks are the property of SOPHiA GENETICS and/or its affiliate(s) in the U.S. and/or other countries. All other names, logos, and other trademarks are the property of their respective owners.